Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis
ClinicalTrials.gov study NCT04120519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GM-CSF With Post-Transplant Cyclophosphamide
ClinicalTrials.gov study NCT04237623. IPD Sharing: NO. Countries: 1. Publications: 0.
Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)
ClinicalTrials.gov study NCT03802773. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer
ClinicalTrials.gov study NCT03971045. IPD Sharing: YES. Countries: 1. Publications: 0.
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02629809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors
ClinicalTrials.gov study NCT00628732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center
ClinicalTrials.gov study NCT05816694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
ClinicalTrials.gov study NCT03263767. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
ClinicalTrials.gov study NCT04290793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
ClinicalTrials.gov study NCT00002943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00083161. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT02948101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
ClinicalTrials.gov study NCT00641381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
ClinicalTrials.gov study NCT00819806. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
ClinicalTrials.gov study NCT05895201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A
ClinicalTrials.gov study NCT02732678. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT02461888. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
ClinicalTrials.gov study NCT03850366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
ClinicalTrials.gov study NCT02954939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Di
ClinicalTrials.gov study NCT06683885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.